Addressing Questions & Unmet Needs in Melanoma Research and Treatment

The landscape for melanoma research and treatment has rapidly changed over the last decade. Since 2011, the FDA has approved 12 new melanoma treatment regimens – including new classes of drugs that are molecularly targeted therapies (BRAF/MEK inhibitors), immune checkpoint inhibitors (anti CTLA-4, PD-1/PD-L1) and other immunotherapies (e.g. T-Vec). Scientists have also unraveled many of the genomic mutations found in the most common form, cutaneous melanoma, melanoma that arises primarily on sun-exposed areas of the skin. With these advances in research and treatment, the key unanswered questions have changed rapidly and existing preclinical models may not be sufficient to answer such questions surrounding immune checkpoint inhibition; resistance development, comparing to cuaneous melanoma, and how to improve early detection.

Importantly, there are no models that accurately predict the patient journey. New models and additional research is needed to more fully represent all melanoma subtypes, stages, or treatment responses.

Related whitepapers, case studies, etc.

Elsevier's Life Science Solutions,COVID-19 search strategies in PharmaPendium: Focus on DMPK and DDIs

Marnix Wieffer

17 September 2020

View webinar

COVID-19 search strategies in PharmaPendium: Focus on drug safety and efficacy

Marnix Wieffer

10 September 2020

View webinar

Text mining as a solution:  Find disease-related genetic variation in literature

George Jiang

2 September 2020

View webinar

Webinars that may also interest you

Scopus,Researchers: CiteScore 2019 and the responsible use of metrics

Hans Zijlstra (Research Metrics Product Manager) and Aileen Christensen (Senior Marketing Manager)

29 June 2020

View webinar

The many helpful applications of journal impact metrics

Hans Zijlstra (Product Manager, Research Metrics) and Aileen Christensen (Senior Marketing Manager)

24 June 2020

View webinar

Scopus APIs: Getting started with Scopus search

Martin Edling Andersson, Principal Product Manager and Aileen Christensen, Senior Marketing Manager

23 June 2020

View webinar